Veliflapon

Overview

Veliflapon (BAY X 1005; DG-031) is an orally active and selective 5-lipoxygenase activating protein ( FLAP ) inhibitor. Veliflapon inhibits the synthesis of the leukotrienes B4 and C4 .

Application

Products | Products > Disease Areas > Arthritis | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > Rheumatoid Arthritis | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Musculoskeletal and Skin Disease | Products > Disease Areas > Autoimmune Disease | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > FLAP | Products > Signaling Pathways > Leukotriene Receptor

Product Information

• Catalog No.: HY-14165
• CAS No.: 128253-31-6
• Molecular Formula: C23H23NO3
• Molecular Weight: 361.43
• Purity: 99.31%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source